scispace - formally typeset
T

Triparna Sen

Researcher at Memorial Sloan Kettering Cancer Center

Publications -  82
Citations -  3287

Triparna Sen is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Cancer & Cancer research. The author has an hindex of 25, co-authored 57 publications receiving 1709 citations. Previous affiliations of Triparna Sen include Washington University in St. Louis & National Cancer Research Institute.

Papers
More filters
Journal ArticleDOI

Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer

TL;DR: This study shows that targeting the DNA damage response (DDR) proteins PARP and checkpoint kinase 1 (CHK1) significantly increased protein and surface expression of PD-L1 and supports a role of innate immune STING pathway in DDR-mediated antitumor immunity in SCLC.
Journal ArticleDOI

The Human Tumor Atlas Network: Charting Tumor Transitions Across Space and Time at Single-Cell Resolution

Orit Rozenblatt-Rosen, +373 more
- 16 Apr 2020 - 
TL;DR: The Human Tumor Atlas Network (HTAN), part of the NCI Cancer Moonshot Initiative, will establish a clinical, experimental, computational, and organizational framework to generate informative and accessible three-dimensional atlases of cancer transitions for a diverse set of tumor types.
Journal ArticleDOI

Lineage plasticity in cancer: a shared pathway of therapeutic resistance.

TL;DR: An overview of the impact of lineage plasticity on cancer progression and therapy resistance, with a focus on neuroendocrine transformation in lung and prostate tumours is provided, and the current understanding of the molecular drivers of this phenomenon is discussed.
Journal ArticleDOI

CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future.

TL;DR: Although it has apparent advantages, CRISPR/Cas9 brings its own set of limitations which must be addressed for safe and efficient clinical translation, and the best strategy to move forward with this powerful but still relatively new technology is considered.